Literature DB >> 3290025

Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications.

M D Maines1.   

Abstract

In biological systems oxidation of heme is carried out by two isozymes of the microsomal heme oxygenase, HO-1 and HO-2. HO-1 is the commonly known heme oxygenase, the activity of which can be induced by up to 100-fold in response to a wide variety of stimuli (metals, heme, hormones, etc.). HO-2 was only recently discovered, and the isozyme appears to be uninducible. The two forms are products of two different genes and differ in their tissue expression. The primary structure of HO-1 and an HO-2 fragment of 91 amino acid residues show only 58% homology, but share a region with 100% secondary structure homology. This region is believed to be the catalytic site. Most likely, HO-1 gene is regulated in the same manner as metallothione in the gene. HO-1 has a heat shock regulatory element, and possibly many promoter elements, which bind to respective inducers and cause transcription of the gene. In vivo induction of HO-1 activity in the liver is accompanied by decreases in the total P-450 levels and, in a reconstituted system, cytochrome P-450b heme can be quantitatively converted to biliverdin by HO-1 and HO-2. The enzyme activity is inhibited in vivo for extended periods subsequent to binding of Zn- and Sn- protoporphyrins. This property appears useful for the suppression of bilirubin production. The metalloporphyrins, however, are not innocuous and cause major disruptions in cellular metabolism. In this review recent findings on heme oxygenase are highlighted.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290025

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  368 in total

Review 1.  Self-cytoprotection against stress: feedback regulation of heme-dependent metabolism.

Authors:  P M Schwartsburd
Journal:  Cell Stress Chaperones       Date:  2001-01       Impact factor: 3.667

2.  The case of CO signaling: why the jury is still out.

Authors:  S P Cary; M A Marletta
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.

Authors:  K Ishikawa; M Navab; N Leitinger; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumors.

Authors:  Jun Fang; Haibo Qin; Hideaki Nakamura; Kenji Tsukigawa; Takashi Shin; Hiroshi Maeda
Journal:  Cancer Sci       Date:  2012-01-16       Impact factor: 6.716

5.  Induction of inducible heme oxygenase (HO-1) in the central nervous system: is HO-1 helpful or harmful?

Authors:  Y Matsuoka; M Okazaki; Y Kitamura
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

6.  The Phytochrome-Deficient pcd1 Mutant of Pea Is Unable to Convert Heme to Biliverdin IX[alpha].

Authors:  J. L. Weller; M. J. Terry; C. Rameau; J. B. Reid; R. E. Kendrick
Journal:  Plant Cell       Date:  1996-01       Impact factor: 11.277

Review 7.  Excretion of biliary compounds during intrauterine life.

Authors:  Rocio I R Macias; Jose J G Marin; Maria A Serrano
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

8.  Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

Authors:  M A Smith; R K Kutty; P L Richey; S D Yan; D Stern; G J Chader; B Wiggert; R B Petersen; G Perry
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 9.  Carbon monoxide--physiology, detection and controlled release.

Authors:  Stefan H Heinemann; Toshinori Hoshi; Matthias Westerhausen; Alexander Schiller
Journal:  Chem Commun (Camb)       Date:  2014-04-11       Impact factor: 6.222

10.  Regulation of c-jun expression during hypoxic and low-glucose stress.

Authors:  W A Ausserer; B Bourrat-Floeck; C J Green; K R Laderoute; R M Sutherland
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.